Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sterling Pharma Solutions announced that it has expanded its bioanalytical services offering at its Deeside, UK site, which is the company’s dedicated facility for antibody-drug conjugates (ADCs).
read more
EUROAPI announced the implementation of a 5-year development and manufacturing agreement with Priothera, a biotechnology company specializing in molecules for the treatment of hematological malignancies and for the improvement of CAR-T cell therapies...
read more
Great Point Partners, an investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH (“Lyocontract”), a premium independent drug product contract development and manufacturing organization (“CDMO”) ...
read more
Bay Area Research Logistics (BARL), a clinical trial services company announced its physical expansion into the US market with the opening of a new depot in New York State. BARL has been providing clinical supply services since 2007 for all phases of...
read more
Charles River Laboratories International, Inc. and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, announced a plasmid DNA and retrovirus vector production program agreement.
read more
Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of high-risk infections and pre-cancerous lesions caused by human papilloma virus (HPV) in women, announced the formation of a scientific and ...
read more
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project. Shifting NIIMBL's ...
read more
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109 (NCT06332755; LG project code LR19155), LG Chem's first proprietary anti-cancer ...
read more
Nykode Therapeutic, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, announced updates on its mRNA platform at the Cancer Immunotherapy meeting in Boston.
read more
Adcytherix SAS announced its incorporation and seed funding of € 30 million to develop novel antibody-drug- conjugates (ADCs) for the treatment of high unmet need diseases such as cancer.
read more
EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD).
read more
CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program.
read more
REPROCELL has been producing clinically relevant human induced pluripotent stem cells (hiPSCs) by controlling the process of donor recruitment to seed stock hiPSC and encompassing donor eligibility with different geographical regulatory agencies.
read more
Eurofins CDMO Alphora Inc. announced a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold. Located in Mississauga, Canada, the expanded facility marks the addition of specialized equipment ...
read more
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced a $3 million investment at its Germantown, WI facility, to expand its integrated antibody-drug conjugate (ADC) development and manufacturing ...
read more